Загрузка...
Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study
The mammalian target of rapamycin plays an important role in multiple myeloma. The allosteric mammalian target of rapamycin inhibitor everolimus has long been approved for immunosuppression and has shown activity in certain cancers. This investigator-initiated phase I trial explored the use of evero...
Сохранить в:
| Опубликовано в: : | Haematologica |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Ferrata Storti Foundation
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4380728/ https://ncbi.nlm.nih.gov/pubmed/25682600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.116269 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|